Clinical trial
Active Immunization of Sibling Bone Marrow Transplant Donors Against Purified…
NCT00001561 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00001561 |
|---|---|
| Title | Active Immunization of Sibling Bone Marrow Transplant Donors Against Purified Myeloma Protein of the Recipient Undergoing Allogeneic Bone Marrow Transplantation |
| Official title | Active Immunization of Sibling Bone Marrow Transplant Donors Against Purified Myeloma Protein of the Recipient Undergoing Allogeneic Bone Marrow Transplantation |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Graft vs Host Disease, Multiple Myeloma |
| Intervention type | Drug |
| Interventions | Myeloma Immunoglobulin Idiotype Vaccine-KLH, GM-CSF |
| Enrollment | 30 |
| Start date | Nov 1, 1996 |
| Completion | Sep 1, 2005 |
| First posted | Nov 4, 1999 |
| Last update posted | Sep 24, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: